Cargando…

SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD

BACKGROUND: Recent surveys in chronic inflammatory rheumatic diseases (CIRD) showed a high degree of vaccine hesitancy. Current knowledge about patients’ attitudes toward vaccination against SARS-CoV-2 is limited. OBJECTIVES: To assess the willingness of CIRD patients to be vaccinated against SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roman, Iulia, Andreica, Ioana, Baraliakos, Xenofon, Redeker, Imke, Kiltz, Uta, Braun, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189521/ https://www.ncbi.nlm.nih.gov/pubmed/35707223 http://dx.doi.org/10.1177/1759720X221093760

Ejemplares similares

Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study
por: Andreica, Ioana, et al.
Publicado: (2023)

CIRD-F: Spread and Influence of COVID-19 in China
por: Zhou, Lingyun, et al.
Publicado: (2020)

Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care
por: Redeker, Imke, et al.
Publicado: (2023)

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases
por: Kiltz, Uta, et al.
Publicado: (2022)

Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study
por: Kiltz, Uta, et al.
Publicado: (2021)

Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review
por: Neusser, Silke, et al.
Publicado: (2022)

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
por: Andreica, Ioana, et al.
Publicado: (2022)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
por: Braun, Jürgen, et al.
Publicado: (2022)

Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence
por: Braun, Jürgen, et al.
Publicado: (2021)

Do patients with ankylosing spondylitis adapt to their disease? Evidence from a ‘then-test’ in patients treated with TNF inhibitors
por: Essers, Ivette, et al.
Publicado: (2015)

Wie viele Patienten mit entzündlich rheumatischen Erkrankungen haben die technischen Voraussetzungen für Videosprechstunden und sind bereit, fachärztliche Visiten so durchzuführen?
por: Baraliakos, X., et al.
Publicado: (2021)

Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases
por: Waldecker-Gall, Sabina, et al.
Publicado: (2023)

Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance data
por: Redeker, Imke, et al.
Publicado: (2022)

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness‐to‐Pay Approach
por: Webers, Casper, et al.
Publicado: (2018)

Wie gut sind Patienten mit entzündlich rheumatischen Erkrankungen gegen Masern geschützt?
por: Kiltz, U., et al.
Publicado: (2020)

Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study
por: Kiltz, Uta, et al.
Publicado: (2017)

Chronic but not inflammatory changes at the Achilles’ tendon differentiate patients with peripheral spondyloarthritis from other diagnoses – Results from a prospective clinical trial
por: Baraliakos, Xenofon, et al.
Publicado: (2017)

„Verankerung“ von Klassifikationskriterien für axiale Spondyloarthritis – wie weit ist gut für die Diagnosestellung?
por: Braun, J., et al.
Publicado: (2020)

Attitude towards and perception of individual safety after SARS-CoV-2 vaccination among German cancer patients
por: Overheu, Oliver, et al.
Publicado: (2022)

The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
por: Webers, Casper, et al.
Publicado: (2022)

Leitfaden „Geschlechtergerechte Sprache in der DGRh e. V.“
por: Haase, Isabell, et al.
Publicado: (2022)

Drohende Corona-Endemie in einer rheumatologischen Spezialklinik – relative Entwarnung durch konsequente Testung
por: Andreica, I., et al.
Publicado: (2021)

‘Status Quo’ on Different Aspects of Gender Distribution in Rheumatology in Germany—Results from a Nationwide Online Survey among Physicians
por: Ohrndorf, Sarah, et al.
Publicado: (2023)

Mit RheMIT können Rheumazentren an der bundesweiten Kerndokumentation teilnehmen – Erweiterung der rheumatologischen Langzeitdokumentation
por: Callhoff, Johanna, et al.
Publicado: (2023)

Standardisierte Erfassung der gesundheitsbezogenen Lebensqualität bei Patienten mit Psoriasisarthritis: Validierung der deutschen Version des „Fragebogen zur Lebensqualität von Patienten mit Psoriasisarthritis (PsAQoL)“
por: Kiltz, U., et al.
Publicado: (2020)

Value of imaging to guide interventional procedures in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Bosch, Philipp, et al.
Publicado: (2021)

Current Practice of Imaging-Guided Interventional Procedures in Rheumatic and Musculoskeletal Diseases: Results of a Multinational Multidisciplinary Survey
por: Carubbi, Francesco, et al.
Publicado: (2021)

High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis
por: Krekeler, Martin, et al.
Publicado: (2022)

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52‐Week, Randomized, Controlled Trial
por: Walsh, Jessica A., et al.
Publicado: (2022)

Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial
por: Trampisch, Ulrike S, et al.
Publicado: (2014)

Dopamine receptor 1 expressing B cells exert a proinflammatory role in female patients with rheumatoid arthritis
por: Wieber, Karolin, et al.
Publicado: (2022)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
por: Poddubnyy, Denis, et al.
Publicado: (2020)

Me Without My Smartphone? Never! Predictors of Willingness for Smartphone Separation and Nomophobia
por: Muench, Ricardo, et al.
Publicado: (2020)

Which disease-related factors influence patients’ and physicians’ willingness to consider joint replacement in hip and knee OA? Results of a questionnaire survey linked to claims data
por: Postler, Anne, et al.
Publicado: (2020)

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1
por: Braun, Jürgen, et al.
Publicado: (2021)

The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
por: Baraliakos, Xenofon, et al.
Publicado: (2008)

SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study
por: Saadoun, David, et al.
Publicado: (2021)

Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time
por: Baraliakos, Xenofon, et al.
Publicado: (2017)

Pearls and Pitfalls in Diagnosing Non-Radiographic Axial Spondyloarthritis
por: Tsiami, Styliani, et al.
Publicado: (2022)

What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis?
por: Schütz, Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d87n9tvnoib5p14aq2njuacgh2